ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TRDA vs PEPG // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Entrada Therapeutics Inc. (NASDAQ) VS. PepGen Inc. (NASDAQ) • 15-METRIC TALLY: TRDA 1 — PEPG 2
■ METRIC PARITY
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRDA VS. PEPG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TRDA PEPG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 PEPG /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.7 42.0 -1.28 PEPG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $171.3M $166.9M $4.4M TRDA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TRDA REV PEPG REV TRDA GROSS % PEPG GROSS % TRDA FCF PEPG FCF
FY 2025 $25.4M $0 — — -$129.6M -$81.9M
FY 2024 $210.8M $0 — — -$44.7M -$82.9M
FY 2023 $129.0M $0 — — $139.8M -$69.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRDA // BETA —
PEPG // BETA —